QS Investors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $351K | Hold |
8,195
| – | – | ﹤0.01% | 886 |
|
|
2021
Q1 | $343K | Sell |
8,195
-100
| -1% | -$4.19K | ﹤0.01% | 931 |
|
|
2020
Q4 | $386K | Hold |
8,295
| – | – | ﹤0.01% | 900 |
|
|
2020
Q3 | $353K | Sell |
8,295
-31,762
| -79% | -$1.35M | ﹤0.01% | 858 |
|
|
2020
Q2 | $1.92M | Hold |
40,057
| – | – | 0.03% | 509 |
|
|
2020
Q1 | $1.84M | Hold |
40,057
| – | – | 0.03% | 447 |
|
|
2019
Q4 | $2.41M | Sell |
40,057
-745
| -2% | -$44.7K | 0.02% | 532 |
|
|
2019
Q3 | $2.31M | Hold |
40,802
| – | – | 0.03% | 522 |
|
|
2019
Q2 | $2.27M | Sell |
40,802
-1,024
| -2% | -$57K | 0.02% | 540 |
|
|
2019
Q1 | $2.11M | Hold |
41,826
| – | – | 0.02% | 587 |
|
|
2018
Q4 | $1.69M | Hold |
41,826
| – | – | 0.02% | 612 |
|
|
2018
Q3 | $2.9M | Hold |
41,826
| – | – | 0.03% | 487 |
|
|
2018
Q2 | $3.17M | Hold |
41,826
| – | – | 0.03% | 451 |
|
|
2018
Q1 | $2.2M | Sell |
41,826
-2,998
| -7% | -$158K | 0.02% | 547 |
|
|
2017
Q4 | $2.39M | Sell |
44,824
-409
| -0.9% | -$21.8K | 0.02% | 544 |
|
|
2017
Q3 | $2.7M | Sell |
45,233
-1,467
| -3% | -$87.5K | 0.02% | 508 |
|
|
2017
Q2 | $3.68M | Hold |
46,700
| – | – | 0.03% | 409 |
|
|
2017
Q1 | $3.87M | Sell |
46,700
-2,183
| -4% | -$181K | 0.03% | 381 |
|
|
2016
Q4 | $3.88M | Sell |
48,883
-11,215
| -19% | -$890K | 0.03% | 421 |
|
|
2016
Q3 | $4.21M | Sell |
60,098
-16,200
| -21% | -$1.13M | 0.03% | 428 |
|
|
2016
Q2 | $2.96M | Hold |
76,298
| – | – | 0.03% | 545 |
|
|
2016
Q1 | $3.09M | Hold |
76,298
| – | – | 0.03% | 533 |
|
|
2015
Q4 | $6.77M | Buy |
76,298
+19,201
| +34% | +$1.7M | 0.07% | 289 |
|
|
2015
Q3 | $4.23M | Hold |
57,097
| – | – | 0.04% | 415 |
|
|
2015
Q2 | $4.62M | Buy |
+57,097
| New | +$4.62M | 0.06% | 409 |
|